Teniposide and cisplatin given by intraperitoneal administration: preclinical and phase I/pharmacokinetic studies.

MLA

Chatelut, E., et al. “Teniposide and Cisplatin given by Intraperitoneal Administration: Preclinical and Phase I/Pharmacokinetic Studies.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 2, no. 3, Mar. 1991, pp. 217–21. EBSCOhost, https://doi.org/10.1093/oxfordjournals.annonc.a057910.

APA

Chatelut, E., de Forni, M., Canal, P., Chevreau, C., Roche, H., Plusquellec, Y., Johnson, N. P., Houin, G., & Bugat, R. (1991). Teniposide and cisplatin given by intraperitoneal administration: preclinical and phase I/pharmacokinetic studies. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 2(3), 217–221. https://doi.org/10.1093/oxfordjournals.annonc.a057910

Chicago

Chatelut, E, M de Forni, P Canal, C Chevreau, H Roche, Y Plusquellec, N P Johnson, G Houin, and R Bugat. 1991. “Teniposide and Cisplatin given by Intraperitoneal Administration: Preclinical and Phase I/Pharmacokinetic Studies.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 2 (3): 217–21. doi:10.1093/oxfordjournals.annonc.a057910.